Westover Medical leads UK charge for Biophysical's biomarkers test
This article was originally published in Clinica
Executive Summary
Biophysical, a US developer of biomarker-based technologies, is set to make its much-publicised Biophysical250 test available in the UK through an exclusive licensing deal with Westover Medical. The deal, of which financial terms were not disclosed, will see Westover, a UK private healthcare provider, offer the test in its two existing clinics in London and in a third to be opened in the capital later this year.
You may also be interested in...
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.
Mary Beth Clarke, CDER Exec Programs Office Director And Generic User Fee Shepherd, Will Retire
Clarke helped launch GDUFA I and negotiate GDUFA II, chaired the CDER Executive Committee and oversaw many other programs in the US FDA’s drugs center.